1. Home
  2. HLX vs IMCR Comparison

HLX vs IMCR Comparison

Compare HLX & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$10.12

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.95

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
IMCR
Founded
1979
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
HLX
IMCR
Price
$10.12
$28.95
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$11.50
$66.33
AVG Volume (30 Days)
2.0M
325.0K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
0.25
Revenue
$876,561,000.00
$249,428,000.00
Revenue This Year
$2.05
$14.57
Revenue Next Year
$5.46
$8.21
P/E Ratio
N/A
$116.16
Revenue Growth
3.60
43.05
52 Week Low
$5.52
$27.56
52 Week High
$10.75
$40.71

Technical Indicators

Market Signals
Indicator
HLX
IMCR
Relative Strength Index (RSI) 55.74 41.69
Support Level $9.22 $27.56
Resistance Level $10.52 $31.56
Average True Range (ATR) 0.33 1.25
MACD -0.01 0.03
Stochastic Oscillator 60.56 25.48

Price Performance

Historical Comparison
HLX
IMCR

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: